One of the most surprising and actively researched areas of oral-systemic health is the connection between oral bacteria and cancer — particularly colorectal cancer. Specific oral bacteria, most notably Fusobacterium nucleatum (Fn), have been found inside colorectal tumor tissue at levels far higher than in surrounding healthy tissue.
Fn is capable of adhering to and invading epithelial cells, promoting inflammation, and potentially driving cellular changes that favor tumor growth. Research suggests it may not just be a bystander but an active participant in tumor development and progression.
Beyond colorectal cancer, oral bacteria have been detected in pancreatic, oral, and esophageal cancers. While causation is not yet established, the consistent presence of specific oral pathogens in tumor tissue across multiple cancer types has prompted significant research investment.
Fusobacterium nucleatum expresses a surface protein called FadA that allows it to bind to and invade epithelial cells. Once inside, it can activate inflammatory signaling and cellular growth pathways (beta-catenin) associated with cancer development.
Fn promotes a pro-inflammatory tumor microenvironment that can suppress anti-tumor immune responses, potentially allowing tumors to evade detection and grow more aggressively.
Fn has been found in colorectal tumor tissue and metastases, suggesting it may travel with cancer cells and contribute to disease spread. Antibiotics targeting Fn in mouse models have slowed tumor growth.
Chronic inflammation from periodontal disease produces systemic inflammatory mediators that may create an environment favorable to cancer development throughout the body.
- 1Fusobacterium nucleatum found in colorectal tumor tissue at much higher levels than normal tissue.
- 2Fn detected in colorectal cancer metastases — may travel with tumor cells.
- 3Fn promotes tumor growth and suppresses anti-tumor immunity in laboratory models.
- 4Higher Fn levels in tumors associated with worse prognosis in colorectal cancer.
- 5Oral bacteria also detected in pancreatic, esophageal, and oral cancers.
- 6Periodontal disease associated with increased cancer risk in observational studies.
Found in colorectal tumors; promotes inflammation and tumor growth
Promotes cellular changes; detected in oral and esophageal cancers
Found in colorectal tumor tissue
Detected in colorectal cancer tissue
- Maintain excellent oral hygiene — reducing pathogenic bacterial load may reduce systemic exposure
- Treat periodontal disease promptly to reduce chronic inflammation
- Keep up with recommended cancer screenings (colonoscopy, etc.) — early detection saves lives
- Share oral health history with your oncologist or gastroenterologist if you have cancer risk factors
- Consider salivary testing to identify high-risk pathogens like Fn
- Eat a high-fiber, plant-forward diet — fiber feeds beneficial gut bacteria that may compete with pathogens
Consider testing if you have a family history of colorectal cancer, a personal history of polyps, or chronic periodontal disease. Also valuable if you have inflammatory bowel disease or are at elevated cancer risk. Note: oral bacteria testing is educational and does not screen for or diagnose cancer.
Kostic AD et al. Fusobacterium nucleatum in colorectal carcinoma. Genome Research. — Fn enrichment in colorectal tumors.
Rubinstein MR et al. Fn promotes colorectal carcinogenesis. — FadA adhesin mechanism linking Fn to tumor growth.
Bullman S et al. Analysis of Fn persistence in colorectal cancer. — Fn found in metastases.